BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $320,568 | +0.3% | 8,494 | +21.1% | 0.02% | +6.7% |
Q2 2023 | $319,555 | +21.4% | 7,014 | +8.0% | 0.02% | +7.1% |
Q1 2023 | $263,297 | -95.2% | 6,492 | -92.4% | 0.01% | -95.5% |
Q2 2022 | $5,521,000 | -20.8% | 85,952 | -4.4% | 0.31% | -10.9% |
Q1 2022 | $6,969,000 | -11.0% | 89,874 | -1.5% | 0.35% | -7.7% |
Q4 2021 | $7,833,000 | -16.2% | 91,253 | -21.5% | 0.38% | -6.7% |
Q3 2021 | $9,345,000 | +46.3% | 116,184 | +46.4% | 0.41% | +17.7% |
Q2 2021 | $6,387,000 | +0.6% | 79,339 | +5.4% | 0.34% | -8.2% |
Q1 2021 | $6,347,000 | +22.0% | 75,257 | +16.0% | 0.38% | +5.9% |
Q4 2020 | $5,204,000 | -3.9% | 64,856 | -3.7% | 0.36% | +23.7% |
Q3 2020 | $5,414,000 | +0.5% | 67,322 | +7.6% | 0.29% | -38.5% |
Q2 2020 | $5,388,000 | +24.9% | 62,579 | +17.8% | 0.47% | -39.3% |
Q1 2020 | $4,313,000 | +7.5% | 53,119 | +10.7% | 0.77% | +10.6% |
Q4 2019 | $4,012,000 | +2.3% | 47,975 | +7.0% | 0.70% | -17.6% |
Q3 2019 | $3,922,000 | +12.7% | 44,835 | +5.5% | 0.84% | +3.8% |
Q2 2019 | $3,480,000 | -3.8% | 42,485 | -4.5% | 0.81% | -5.5% |
Q1 2019 | $3,617,000 | +27.1% | 44,483 | +2.9% | 0.86% | +12.4% |
Q4 2018 | $2,845,000 | -11.9% | 43,228 | +3.2% | 0.76% | +1.7% |
Q3 2018 | $3,229,000 | +16.1% | 41,884 | +11.2% | 0.75% | -3.1% |
Q2 2018 | $2,782,000 | +25.2% | 37,675 | +10.3% | 0.78% | +17.2% |
Q1 2018 | $2,222,000 | +11.4% | 34,159 | +10.7% | 0.66% | +10.0% |
Q4 2017 | $1,994,000 | +36.7% | 30,850 | +32.6% | 0.60% | +24.9% |
Q3 2017 | $1,459,000 | +2291.8% | 23,258 | +2561.1% | 0.48% | +1750.0% |
Q1 2013 | $61,000 | – | 874 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |